#United States #New York #Securities Fraud #Pomerantz Law #Hims & Hers

Pomerantz Law Firm Sheds Light on Class Action Against Hims & Hers Health, Inc.

The Pomerantz Law Firm, renowned for its expertise in securities class actions, has recently announced a significant development for investors of Hims & Hers Health, Inc. This New York-based law firm is urging investors who have suffered losses on their investments in Hims & Hers to consider participating in a class action lawsuit. The lawsuit centers around allegations of securities fraud and misleading business practices that could have affected many investors.

On October 15, 2026, Pomerantz stated that the class action concerns whether Hims & Hers, along with certain corporate officers or directors, engaged in practices that misled investors about the company’s business integrity. Interested investors have until November 2, 2026, to appoint themselves as Lead Plaintiffs if they acquired Hims & Hers securities during the relevant period.

According to recent reports, the troubles for Hims & Hers escalated after a lawsuit was filed by the Federal Trade Commission (FTC). The FTC claimed that the telehealth provider mishandled consumer data and made deceptive claims about its services. Allegations include sharing sensitive health information with third-party advertisers while falsely assuring consumers that their privacy was protected. Furthermore, the complaint highlighted that Hims & Hers failed to disclose its billing methods, prompting consumers to incur charges for prescriptions prior to a necessary consultation regarding their treatment options.

As a result of these allegations, the company's stock took a significant hit, plummeting by $4.32 per share, translating to a nearly 15% drop, to close at $25.00 per share. This reduction reflects growing investor concerns and underscores the importance of legal action for those who feel misled by the company's promises.

Pomerantz Law Firm boasts a rich history in championing the rights of investors and fighting against corporate misconduct. Founded by Abraham L. Pomerantz, the firm has established itself as a leader in securities class action litigation and has secured numerous substantial awards for class members. The firm’s involvement in this case signifies its commitment to advocating for investors who have been adversely impacted by corporate fraud and unethical behavior.

Investors who believe they may have been affected by this situation are encouraged to reach out to Pomerantz. The firm can provide guidance on how to proceed with joining the class action and all associated legal processes. Interested investors are advised to include their contact information, such as their mailing address and telephone number, along with the number of shares purchased when reaching out.

For more details on the class action lawsuit and how to participate, potential plaintiffs can visit the Pomerantz website. This case exemplifies the ongoing challenges within the corporate landscape, highlighting the necessity for vigilant oversight and accountability.

By keeping investors informed about critical deadlines and their legal options, Pomerantz Law Firm aims to empower those who have faced losses in the stock market due to potentially deceptive practices.

In conclusion, if you are an investor of Hims & Hers Health, Inc. and have incurred losses due to the allegations outlined, now is the time to consider your legal rights and options. The Pomerantz Law Firm remains committed to protecting investors and holding companies accountable for their actions.